GWM
AATC

Geneos Wealth Management’s Autoscope Technologies Corporation Common Stock AATC Stock Holding History

Geneos Wealth Management’s Portfolio AATC Stock Details AATC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,500
Closed -$8K – 2713
2022
Q2 		$8K Hold
1,500
– – ﹤0.01% 2061
2022
Q1 		$9K Buy
+1,500
New +$9.91K ﹤0.01% 2150

Other funds holding AATC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geneos Wealth Management's AATC Position: Q3 2022 in Review

Geneos Wealth Management sold out of Autoscope Technologies Corporation Common Stock (AATC) in Q3 2022, closing a stake of 1,500 shares — an estimated $8K sold.

Geneos Wealth Management first reported a position in AATC in Q1 2022 and held it in 2 quarters. The position peaked at $9K in Q1 2022. 19 funds tracked by Wall St. Rank hold AATC as of Q3 2022.

  • Geneos Wealth Management reported no remaining Autoscope Technologies Corporation Common Stock position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 1,500 Autoscope Technologies Corporation Common Stock shares in Q3 2022, an estimated $8K.
  • Geneos Wealth Management first reported a position in Autoscope Technologies Corporation Common Stock in Q1 2022 and held it in 2 quarters.
  • Geneos Wealth Management's Autoscope Technologies Corporation Common Stock position peaked at $9K in Q1 2022.
  • 19 funds tracked by Wall St. Rank held Autoscope Technologies Corporation Common Stock as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.